Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
The Latest on: Fecal transplants
via Google News
The Latest on: Fecal transplants
- Inside the strange world of fecal transplantson January 30, 2020 at 8:03 am
In the worst cases, it can be fatal. Even when vanquished by antibiotics, it can return except if the patient receives an infusion of poo, a procedure known as a fecal microbiota transplant (FMT).
- Fecal microbiota transplantation in children does not significantly alter body mass index.on January 30, 2020 at 7:35 am
Fecal microbiota transplantation (FMT) is nowadays a promising therapy for Clostridium difficile infection (CDI) and a potential treatment for ulcerative colitis. However, it is still unclear whether ...
- Sibling donation of FMT linked to long-term UC remissionon January 28, 2020 at 6:20 am
AUSTIN, Texas — The use of sibling donation for fecal microbiota transplant led to long-term remission of ulcerative colitis more often than donation from a parent, according to a presenter at the ...
- Your Gut Bacteria Could Be Shaping Your Personalityon January 27, 2020 at 9:25 am
While Johnson's work may one day yield opportunities to adjust aspects of ourselves via the gut, we're a long way from that point. So don't get sucked in by the “gut hype” that seeks to tell you all ...
- Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db miceon January 26, 2020 at 2:24 am
Fig. 2: Staining of live bacteria in fecal samples from KNGT and mice. Fig. 3: Changes in body weight and plasma glycolipid levels in db/db mice treated with fecal bacteria from KNGT. Chinese Diabetes ...
- Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed ratson January 22, 2020 at 2:57 am
Meanwhile, the gut microbiota composition was partially normalized against lead-exposed rats, which in turn mediated the memory repairment via fecal transplantation trials. In the molecular aspect, ...
- Fecal microbiota transferon January 20, 2020 at 3:59 pm
1. Hvas CL, Dahl Jorgensen SM, Jorgensen SP, et al.: Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile Iifection. Gastroenterology 2019; 156: ...
- Heart disease contagious?: Study suggests 'non-communicable' diseases might be spread through gut bacteriaon January 17, 2020 at 4:00 am
If a radical hypothesis being floated by scientists proves correct — that humans can spread heart disease, diabetes and other “non-communicable” conditions via unhealthy microbes in our guts — there ...
- Taking children with autism to Mexico for fecal transplants 'out of scope' for naturopaths, regulator sayson January 14, 2020 at 11:33 am
B.C. naturopath Jason Klop claims he's seen 'dramatic improvements' in symptoms of autism spectrum disorder after performing fecal microbiota transplants on children. (drjasonklop.com) B.C ...
- B.C. naturopath's pricey fecal transplants for autism are experimental and risky, scientists sayon January 10, 2020 at 1:08 am
A Vancouver naturopath who charges $15,000 US for children with autism to have fecal transplants at a clinic near Tijuana, Mexico could put them at serious risk of infection with an unproven treatment ...
via Bing News